![Dr. Katherine Bever](https://www.oncotarget.net/wp-content/uploads/2021/12/Screen-Shot-2021-12-02-at-3.43.02-PM-300x169.png)
Behind the Study: Metformin and Rapamycin as Maintenance Therapy
December 13, 2021
Dr. Katherine Bever from Johns Hopkins University discusses a research paper she co-authored that was published by Oncotarget, “An exploratory study of metformin with or without rapamycin as maintenance therapy... read more